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ABSTRACT
Tyrosyl-DNA phosphodiesterase (TDP1) is a DNA
repair enzyme that removes peptide fragments
linked through tyrosine to the 30 end of DNA, and
can also remove 30-phosphoglycolates (PGs) for-
med by free radical-mediated DNA cleavage. To
assess whether TDP1 is primarily responsible
for PG removal during in vitro end joining of DNA
double-strand breaks (DSBs), whole-cell extracts
were prepared from lymphoblastoid cells derived
either from spinocerebellar ataxia with axonal neuro-
pathy (SCAN1) patients, who have an inactivating
mutation in the active site of TDP1, or from closely
matched normal controls. Whereas extracts from
normal cells catalyzed conversion of 30-PG termini,
both on single-strand oligomers and on 30 overhangs
of DSBs, to 30-phosphate termini, extracts of SCAN1
cells did not process either substrate. Addition of
recombinant TDP1 to SCAN1 extracts restored
30-PG removal, allowing subsequent gap filling on
the aligned DSB ends. Two of three SCAN1 lines
examined were slightly more radiosensitive than
normal cells, but only for fractionated radiation in
plateau phase. The results suggest that the TDP1
mutation in SCAN1 abolishes the 30-PG processing
activity of the enzyme, and that there are no other
enzymes in cell extracts capable of processing pro-
truding 30-PG termini. However, the lack of severe
radiosensitivity suggests that there must be alter-
native, TDP1-independent pathways for repair of
30-PG DSBs.
INTRODUCTION
When transient DNA strand breaks formed by DNA topo-
isomerase I fail to religate, the topoisomerase becomes irre-
versibly attached to the 30 DNA terminus via a tyrosyl linkage
(1,2). This linkage must then be cleaved by tyrosyl-DNA
phosphodiesterase (TDP1) in order to allow repair of the break
(3,4). DNA double-strand breaks (DSBs) induced by radiation
and radiomimetic drugs typically bear 30-phosphoglycolate
(PG) and 30-phosphate termini that must likewise be removed
priortoanygapﬁllingbyDNApolymeraseandrejoiningofthe
break by DNA ligase (5–7). The human apurinic/apyrimidinic
endonuclease Ape1iscapable ofremoving PGsfrom bluntand
recessed 30 ends, albeit inefﬁciently (8), and polynucleotide
kinase/phosphatase (PNKP) can remove 30-phosphates from
blunt, recessed and protruding 30 ends (9,10). However, PGs
on protruding 30 termini are refractory to both these enzymes,
and TDP1 is the only enzyme known to be capable of pro-
cessing such lesions, converting them to 30-phosphates sus-
ceptible to removal by PNKP (8,11). Although previous data
suggested that most of the processing of protruding 30-PG
termini in human cell extracts was indeed attributable to
TDP1 (11), the possibility of alternative PG-processing
enzymes or pathways was not excluded.
The rare hereditary disorder spinocerebellar ataxia with
axonal neuropathy (SCAN1) has been linked to a homozygous
mutationintheactivesiteofTDP1(12).SCAN1patientsexhibit
adolescent-onset ataxia and peripheral neuropathy, accompan-
ied by cerebellar atrophy as detected by magnetic resonance
imaging (12). SCAN1 thus joins ataxia telangiectasia, xero-
derma pigmentosum and Cockayne syndrome as DNA repair
disorders with prominent neurological pathology (13–15).
In order to assess the biological signiﬁcance of 30-PG pro-
cessing by TDP1, radiosensitivity of TDP1-mutant SCAN1
cells was determined, and processing of 30-PG termini was
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cells. While biochemical assays indicated a severe deﬁcit in
30-PG processing in SCAN1 cells, the cells showed only slight
radiosensitivity.
MATERIALS AND METHODS
Materials
Cell lines from SCAN1 patients and from unaffected members
of the same family were generated by transfection of peri-
pheral lymphocytes with Epstein–Barr virus (12). The cells
were maintained in suspension in upright T-75 ﬂasks at a
densityof10
5–10
6/mlinRPMImedium(Gibco)supplemented
with 10% fetal bovine serum. Whole-cell and nuclear extracts
were prepared from  5 · 10
8 cells, as described previously
(16–18). A 30-PG 14mer was prepared by bleomycin cleavage
of a 50-end-labeled 17mer, and an internally labeled 30-PG-
terminated plasmid was generated by ligating this 14mer and
an unlabeled 30-PG 13mer into the two 30-resected ends of
plasmid pSV56, as described previously (19). In order to over-
express TDP1 in human cells, the 1.8 kb BamHI/Bsu36I frag-
ment (with the Bsu36I site converted to a blunt end by ﬁll-in
with T4 DNA polymerase) was isolated from pHN1894S (4)
(generous gift from Howard Nash and Jeff Pouliot, NIMH)
and cloned into the BglII and EcoRV sites of the mamma-
lian expression vector pFLAG-CMV-2 (Sigma–Aldrich).
This vector (pFLAG-TDP1), containing the complete TDP1
coding sequence, was transfected into human 293 cells using
Superfect (Qiagen), and FLAG-TDP1 was puriﬁed on FLAG
afﬁnity beads, as described below.
Radiosensitivity
The cells were grown to plateau phase ( 2 · 10
6/ml) in
24-well plates and irradiated with 0.4–1.6 Gy
137Cs g-rays
(or mock irradiated) each day for 5 days. The cells were
then diluted to 10
5/ml and the concentration of viable (trypan
blue-excluding) cells was monitored for 19 days.
PG processing
To assess processing of 30-PG termini on the oligomeric sub-
strate, 20 fmol of the substrate was incubated at 37 C for 2 h in
5 ml of 60 mM potassium acetate, 50 mM triethanolamine–
HCl, pH 7.4, 2 mM ATP, 5 mM EDTA, 1 mM DTT and
100 mg/ml BSA, containing various amounts of whole-cell
or nuclear extract (2 ml maximum). Samples were heated to
90 C for 5 min to inactivate proteins in the extract, and then
1.5 ml of 50 mM MgCl2 and 0.5 mlo f4 0mg/ml PNKP (gen-
erous gift of Michael Weinfeld, Cross Cancer Institute) were
added and the samples incubated for 1 h at 37 C. An equal
volume of formamide containing 20 mM EDTA was added,
and after denaturation for 1 min at 90 C the samples were
subjected to denaturing electrophoresis on a 20% polyacryl-
amide sequencing gel. Post-treatment with PNKPconverts any
30-phosphate termini generated by TDP1 into 30-OH termini,
thus increasing the separation between the substrate and prod-
uct bands on the gel. Initial screening of SCAN1 and normal
cell lines (Figure 2) was performed in a double-blind fashion.
To assess processing of protruding 30-PG termini on the
plasmid substrate, the substrate was ﬁrst incubated in
whole-cell or nuclear extracts for various times. For whole-
cell extracts, samples contained 10 ng substrate and 60 mg
extract in the incubation buffer described above but with
0.5 mM magnesium acetate instead of EDTA, plus 50 mM
dATP, dGTP, dCTP and ddTTP. Typically, 9 ml of extract
was added to a total reaction volume of 20 ml. Potassium and
magnesium were added to give the ﬁnal concentrations indic-
ated, after compensation for potassium and EDTA in extract
storage buffer. For nuclear extracts, a similar buffer but with
1 mM magnesium acetate and 1 mM ATP was used. Following
incubation at 37 C for various times, the samples were diluted
into 0.14 ml of 1% SDS, 1 mg/ml proteinase K, 0.3 M NaCl,
20 mM Tris–HCl pH 7.6 and 10 mM EDTA, and heated to
65 C for 3 h. Following extraction with phenol and then with
chloroform, the nucleic acids were ethanol-precipitated and
the DNA cut with AvaI (40 U in 50 ml ,3ha t3 7  C) to release
the labeled oligomer. Samples were ethanol-precipitated
in the presence of 2 mg tRNA and subjected to electrophoresis
as above.
Phosphorylation in vivo
Human 293 cells were grown to 50% conﬂuence in 60 mm
dishes and transfected with pFLAG-TDP1 as follows. A mix-
ture of 1.27 ml serum-free medium and 255 ml Superfect
(Qiagen) was preincubated with 42 mg plasmid at room tem-
perature for 10 min and then diluted into 8.5 ml complete
medium. Medium in each dish was replaced with 1 ml of
this transfection medium, and the dishes were rocked at
3 cycles/min at 37 C for 3 h. Following addition of 5 ml com-
plete medium and incubation without rocking for 2 days, the
medium was replaced with 2.5 ml phosphate-free medium
containing 0.5 mCi [
32P]phosphoric acid (Perkin-Elmer,
6000 Ci/mmol). After 30 min incubation, the cells were
exposed to 0 or 20 Gy
60Co g-rays (dose rate 4 Gy/min)
and incubated for various times. The medium was removed
and cells were scraped into 0.8 ml ice-cold phosphate-buffered
saline, pelleted (3000 r.p.m., 4 min) and lysed by resuspending
in 0.2 ml lysis buffer [10 mM HEPES-KOH, pH 7.8, 60 mM
KCl, 1 mM EDTA, 0.5 mM phenylmethlysulfonyl ﬂuoride
(PMSF) and 0.5% NP-40], supplemented with protease inhi-
bitors (Sigma–Aldrich P-8465) and phosphatase inhibitors
(Sigma–Aldrich P-2850 and P-5726), each at 100:1 dilution.
After5minonice,the nucleiwerepelletedandthe supernatant
(cytoplasmic fraction) was decanted. The nuclei were resus-
pended in 0.2 ml Dignam nuclear extraction buffer (20 mM
Tris–HCl, pH 7.9, 0.2 mM EDTA, 0.42 M NaCl, 15 mM
MgCl2, 25% glycerol, plus inhibitors as above), held on ice
for 30 min and then centrifuged at 8000 g for 5 min. The
supernatant (nuclear fraction) was decanted. Each cytoplasmic
ornuclear fraction was diluted with anequal volume of 10 mM
Tris–HCl, pH 7.6, 1 mM EDTA (TE), and prewashed FLAG
afﬁnity beads (30 ml bed volume) were added. FLAG-tagged
TDP1 in the lysates was adsorbed to the beads (3 h at 8 C
with rotation), and the beads were washed three times with
inhibitor-free TE. Aliquots of the beads ( 5 ml bed volume for
each sample) were treated with protein phosphatase 1 (PP1)
(1 U at 30 C for 2 h), washed and then treated with YOP
phosphatase (25 U at 30 C for 2 h), in 40 ml of the buffers
provided by the vendor (New England Biolabs). In each case,
the beads were washed once with the appropriate reaction
buffer before each reaction, and control samples were
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the beads were boiled for 5 min in 62.5 mM Tris–HCl, pH 6.8,
0.1 M 2-mercaptoethanol, 10% glycerol and 2% SDS, and the
denatured proteins analyzed on 10% SDS–polyacrylamide
gels. Proteins were electroblotted onto nitrocellulose and
probed with anti-FLAG antibody (1000:1 dilution; Sigma–
Aldrich F-3165), using a chemiluminescent goat anti-rabbit
secondary antibody (Pierce). The blots were then subjected to
phosphorimaging for 1–2 days to assess
32P incorporation into
FLAG-TDP1.
For preparation of FLAG-TDP1 for reconstitution experi-
ments, the above procedure was scaled up to ﬁve 150 mm
dishes. After adsorption and washing as above, FLAG-TDP1
was eluted from FLAG afﬁnity beads (200 ml bed volume) by
rotating the beads for 16 h in 2.5 bed volumes TE containing
0.5 mM DTT, 0.5 mM PMSF and 160 mg/ml of the peptide
DYKDDDDK (FLAG peptide, Sigma–Aldrich F-3290). An
equal volume of glycerol was added and the enzyme was
stored at  20 C.
RESULTS
Lack of 30-prime-PG processing in SCAN1 extracts
To examine PG processing activities in human normal and
SCAN1 cells, immortal lymphoblastoid cell lines were gen-
erated from SCAN1 patients and from unaffected members of
the same family, including known heterozygous SCAN1 car-
riers. Whole-cell and nuclear extracts were prepared, and a
30-PG-terminated 14mer (Figure 1A) was incubated in various
dilutions of extract (Figure 2). These reactions contained
EDTA, which prevents degradation of the oligomer by potent
single-strand nucleases in the extracts, but also blocks PNKP-
mediated conversion of 30-phosphate termini generated by
TDP1 to 30-OH termini. Therefore, to increase the resolution
of the assay, samples were treated with puriﬁed PNKP after
heat-denaturation of cellular proteins.
Under these conditions, 30-PG termini were quantitatively
removed by incubation in 0.3 mg/ml whole-cell extract,
but there was little if any removal by SCAN1 extracts even
at 3 mg/ml (Figure 2A). Heterozygous TDP1+/– carriers
appeared to have slightly less PG-processing activity, as PG
removal was complete at 1 mg/ml but not at 0.3 mg/ml extract.
As expected, a sample treated with extract but not sub-
sequently treated with PNKP showed predominant accumula-
tion of 30-phosphate termini.
Although there was, in samples treated with SCAN1 whole-
cell extracts, a trace of a band comigrating with the 30-OH
oligomer, the intensity of this band showed no apparent de-
pendence on extract concentration. Moreover, no band was
seen at the 30-OH position in samples treated with a SCAN1
nuclear extract (Figure 2B), even though normal nuclear
extracts contained nearly as much PG-processing activity as
normal whole-cell extracts (Figure 2C). Thus, while the origin
of the apparent 30-OH band generated in SCAN1 whole-cell
extracts is uncertain, it probably does not represent PG pro-
cessing by residual TDP1 activity in the SCAN1 extracts.
Based on titrations with normal and SCAN1 nuclear extracts
(Figure 2B), it is estimated that, in the presence of EDTA,
PG-processing activity is at least 100-fold lower in SCAN1
cells than in normal cells. Thus, as expected, the SCAN1
mutation in the active site of TDP1 (12) apparently abrogates
its activity completely, at least for a PG substrate.
These results also indicate that, in the absence of divalent
cations, nuclear and whole-cell extracts contain no enzymes
capable of processing 30-PG termini, other than TDP1.
However, these data do not exclude the possibility of other
Mg
++-dependent PG-processing enzymes. When the 30-PG
oligomer was incubated in either normal or SCAN1 nuclear
extract in the presence of Mg
++, the
32P-label was completely
converted to material that migrated at the position expected for
asinglenucleotide,suggestingthatitwascompletelydegraded
by nucleases in the extracts. In SCAN1 extracts, the kinetics of
degradation for unmodiﬁed oligomers suggested that both
30!50 and 50!30 exonucleolytic activities were present
(data not shown). However, in similar experiments with the
30-PG oligomer, neither full-length 30-OH oligomer nor any
intermediate-length fragments were visible; all label appeared
as either completely intact or completely degraded substrate,
suggesting predominantly 50!30 digestion, perhaps by exo-
nuclease I (20). This degradation precluded use of the 30-PG
oligomer for assessing Mg
++-dependent PG-processing activ-
ities. Therefore, PG processing was instead examined using a
plasmid substrate (see Figure 1B) bearing an internal label
near one 30 end (Figure 3). In normal whole-cell extracts,
in the presence of Mg
++, conversion of the protruding 30-
PG terminus of this substrate to a 30-OH was nearly complete
within 15 min (Figure 3A). While there was also signiﬁcant
30!50 resection, especially after 6 h, the plasmid substrate
was subject to much less degradation than was the oligomer.
The DNA-dependent protein kinase (DNA-PK) inhibitors
wortmannin and dimethylaminopurine had no apparent effect
on PG processing, and similar PG processing kinetics were
seen in extracts of DNA-PK-deﬁcient M059J cells (21),
implying that PG processing did not require DNA-PK.
A
B
Figure 1. Substrates with 30-PG termini. (A) Oligomeric substrate. The 30-PG
terminus can be converted to a 30-phosphate by TDP1 and thence to a 30-OH
by PNKP. (B) The 5.5 kb 30-PG plasmid substrate is internally labeled, and
30-terminal processing can be monitored by cleaving the substrate with AvaI
and analyzing the labeled fragment by denaturing gel electrophoresis.
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terminated substrate in SCAN1 whole-cell extracts, indicating
that, at least under these in vitro conditions, all PG processing
was attributable to TDP1, and there were no Mg
++-dependent
activities in the extracts capable of processing protruding 30-
PG termini. These data also show that the PG terminus pre-
vented 30!50 resection of the substrate. This resection may be
attributable to DNase III, which is the predominant 30!50
exonuclease in mammalian cell extracts (22,23), and can
digest 30-OH- but not 30-PG-terminated substrates (24).
Unexpectedly and in contrast to the 30-PG oligomer, the
plasmid substrate was subject to much less 30-PG processing
in nuclear than in whole-cell extracts, with only  2% conver-
sion to 30-OH after 6 h incubation in nuclear extracts from
normal cells (Figure 3B). After 24 h incubation (data not
shown), most of the 30-PG bands disappeared, but little or
no 30-OH 14mer was detected, suggesting that the substrate
was eventually either degraded or rendered insoluble. The
disparity in the extent of PG processing between whole-cell
and nuclear extracts was not due to the small differences
between the reaction buffers, as the same result was obtained
using the buffer normally used for whole-cell extracts (lanes
marked ‘asterisk’ in Figure 3B); nor was it due to a lack of
XRCC4/DNA ligase IV complex [a component of the end-
joining repairosome that is often present in suboptimal
amounts in nuclear extracts (17)], as addition of exogenous
XRCC4 and ligase IV had no effect. The inefﬁciency of PG
processing in nuclear extracts may be due to sequestration of
DNA ends by DNA-PK, which is present in higher concentra-
tions in the nucleus than in the cytoplasm (25). In any case, the
small degree of PG processing seen in normal extracts was
completely absent in SCAN1 nuclear extracts, consistent with
its being catalyzed by TDP1 plus PNKP. When the normal
nuclear extract was supplemented with 25 ng of additional,
recombinant TDP1, conversion to 30-OH was increased to
 10%, and nearly all the conversion occurred within the
ﬁrst 15 min (data not shown). This result is consistent with
the view that in nuclear extracts the 30-PG terminus is brieﬂy
accessible to TDP1 before becoming sequestered in a DNA
end-binding complex.
When SCAN1 whole-cell extracts were complemented with
puriﬁed recombinant human TDP1, end processing was qua-
litatively similar to the processing seen in normal whole-cell
extracts, with complete conversion of 30-PG to 30-OH termini
(or to 30-phosphate termini in the presence of EDTA)
(Figure 4). Moreover, when the extracts were also supplemen-
ted with XRCC4/ligase IV complex, which is often rate-
limiting in cell extracts (17), the substrate was extended by
1 nt, consistent with gap ﬁlling on DSB ends aligned by
annealing of the self-complementary -CG at the termini
(ddTTP is incorporated, preventing subsequent ligation; see
Figure 1). Thus, except for XRCC4/ligase IV, all factors
required for this alignment-based gap ﬁlling, which is the
hallmark of the non-homologous end-joining repair pathway
(26,27), were apparently present and active in these extracts.
Phosphorylation of TDP1 in vivo and stimulation by
ionizing radiation
DNA DSBs induced by ionizing radiation initiate an extensive
cascade of phosphorylation events, beginning with ATM and
DNA-PK, and culminating in repair, cell cycle arrest and/or
Figure 2. Processingofa 30-PG14merbyextractsoflymphoblastoidcellsfromSCAN1patients(closedsymbols)andfromunaffectedmembers(opensymbols)of
the same family, including TDP1+/– carriers (squares, males; circles, females). The substrate was treated with 0.3, 1 or 3 mg/ml of each whole-cell extract (A), or
with0.14,1.4or5mg/mlofeachnuclearextract(B)for2hinthepresenceofEDTA.Followingheatdenaturationofcellularproteins,thesubstratewastreatedwith
PNKPtoconvert30-phosphateto30-OHtermini.Titrationwithvariousconcentrationsofextract(C)showedthatwhole-cellextracts(closedcircles)containedabout
twice as much PG-processing activity as nuclear extracts (open squares).
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phosphorylation as part of this cascade. To determine whether
TDP1 is such a target, FLAG-TDP1 was overexpressed from a
transfected plasmid vector in 293 cells in the presence of
[
32P]phosphate, and then afﬁnity-puriﬁed from cell extracts.
A prominent
32P-labeled  70 kDa band, comigrating with the
FLAG-tagged protein detected on western blots, was found in
extracts from transfected but not from untransfected cells,
suggesting that TDP1 was indeed phosphorylated in vivo
(Figure 5). For samples harvested 15 and 240 min after irra-
diation, phosphorylation was signiﬁcantly stimulated by radi-
ation. [The lack of apparent stimulation in the irradiated,
60 min sample may be attributable to low transfection efﬁci-
ency or poor protein recovery in this sample, as suggested by a
relatively weak FLAG-TDP1 band on the western blot
(Figure 5B)]. In a second experiment wherein cytoplasmic
and nuclear fractions were analyzed separately, radiation-
induced stimulation of phosphorylation was detected in
both fractions at all time points (Table 1). The average radi-
ation-induced increase in [
32P]phosphate incorporation into
TDP1 for all nine samples from both experiments was 2.1 –
0.3 fold (mean – SE). These results suggest that TDP1 is a
target for cell signaling in response to radiation. Treatment of
the
32P-labeled FLAG-TDP1 with the serine/threonine-
speciﬁc PP1 eliminated
32P-labeling almost completely, while
the tyrosine-speciﬁc YOP phosphatase had little if any effect
(Figure 6). Thus, TDP1 appears to be phosphorylated predo-
minantly on serine or threonine residues. Although phosphor-
ylationwas stimulated onlyslightlybyirradiation,the baseline
phosphorylation level may have been elevated due to radiation
from the
32P-radiolabel.
Figure 4. Reconstitution of 30-PG processing and subsequent gap filling in
SCAN1extractsbyrecombinantTDP1.Theplasmidsubstratewastreatedwith
3 mg/mlSCAN1whole-cellextract (subject1635)and analyzedas in Figure3.
In some cases, 25 ng of recombinant TDP1 and/or 200 ng of XRCC4/DNA
ligase IV complex (Trevigen) were added. Some samples contained 5 mM
EDTA instead of 0.5 mM MgCl2, as indicated.
Figure 5. Phosphorylation of TDP1. Cells irradiated with 0 or 20 Gy were
incubated in the presence of [
32P]orthophosphate for the indicated times.
Affinity-purified FLAG-TDP1 was subjected to denaturing gel
electrophoresis followed by phosphorimaging (A) or western blotting with
FLAG antibody (B).
Figure 3. Processing of a plasmid bearing partially complementary PG-
terminated 3-base 30 overhangs by normal and SCAN1 extracts. The
substrate was treated for the indicated times with 3 mg/ml whole-cell (A)o r
1.8 mg/ml nuclear extract (B), deproteinized, treated (or not) with PNKP, cut
with AvaI and subjected to denaturing gel electrophoresis. Some samples also
contained 1 mM dimethylaminopurine (DMAP), 10 mM wortmannin (Wort)
and/or 2% dimethyl sulfoxide (DMSO, solvent for wortmannin). The lanes
marked (asterisk) in (B) indicate samples that were treated in the reaction
buffer normally used for whole-cell extract. In (B), all samples treated with
the normal extract showed 1.8–2.1% conversion to 30-OH, while those treated
with the SCAN1 extract showed no detectable conversion. A trace of 14-PG
fragment seen in some samples is due to residual single-strand oligomer that
was not incorporated into the plasmid.
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If 30-PG processing is inefﬁcient or absent in SCAN1 cells
in vivo, then SCAN1 cells should be more sensitive than
normal cells to ionizing radiation, an agent that induces a
high proportion of breaks with 30-PG termini (7). Initial
screening suggested that SCAN1 cells were no more sensitive
than normal cells to a single dose of either radiation or hydro-
gen peroxide (data not shown). However, since DSB repair by
non-homologous end-joining is primarily responsible for split-
dose recovery (32), dose fractionation can accentuate the
radiosensitizing effects of repair deﬁciencies.
Whenplateau-phase cellswere irradiated dailyforﬁvedays,
cell lines from two SCAN1 patients were reproducibly more
radiosensitive than those from two unaffected individuals, as
judged by the subsequent growth delay (Figure 7). For
example, at 5 · 1.6 Gy, growth of normal cells resumed
after 10 days, by which time the SCAN1 cells (subject
1664) had begun to die off (Figure 7D). Comparison of the
response of SCAN1 cells to 5 · 0.8 Gy (Figure 7C and G) with
the response of normal cells to 5 · 1.6 Gy (Figure 7D and H)
suggested that in each case, the degree of radiosensitivity
(dose-modifying factor) was  2-fold, although cells from
SCAN1 subject 1664 (Figure 7D) appeared to be slightly
more sensitive than those from subject 1662 (Figure 7H).
A third SCAN1 line (subject 1635) harboring the same
mutant TDP1 allele and having the same apparent biochemical
deﬁciency (Figure 2) did not show any radiosensitivity, con-
sistently giving growth curves that were superimposable with
those of normal cells (subject 1668) following treatment with
either single-dose or fractionated radiation (data not shown).
However, subjects 1662, 1664 and 1668 are more closely
related to each other than to subject 1635, and thus may be
more appropriate for comparison. Although growth assays
may overlook small differences in radiosensitivity that
might have been detected in clonogenic survival assays, we
were unable to obtain reproducible survival data with any of
these cell lines, by either agar cloning or limiting dilution
assays, due to the low cloning efﬁciency ( 1%). Nevertheless,
while the present results do not distinguish between growth
delay and cell killing, they do show a difference between two
of the three SCAN1 cell lines and normal cell lines in their
response to radiation. Attempts to complement the apparent
radiosensitivity of SCAN1 cells by expression of normal
TDP1 are in progress, but are likewise complicated by the
low cloning efﬁciency of these cells.
DISCUSSION
Because DNA ligases as well as gap-ﬁlling DNA polymerases
require 30-OH substrates, removal of 30-PG termini is an
essential early step in the repair of free radical-mediated
DSBs. Candidates for carrying out such removal include
dedicated 30-terminal processing enzymes such as Ape1,
PNKP and TDP1, as well as 30 exonucleases such as DNase
III, Mre11 and Wrn. However, based on the known speciﬁ-
cities of these enzymes, none of them except TDP1 is expected
to act on protruding 30-PG termini of DSBs. Ape1 acts only on
bluntandrecessed 30 ends(8), andneitherPNKPnorDNaseIII
has any activity toward 30-PG termini (11,24). Although the
Table 1. Radiation-induced enhancement of TDP1 phosphorylation (fold)
Time Experiment 1 Experiment 2
Combined Cytoplasm Nucleus
20 min 3.8 1.4 1.9
1 h 1.1 1.6 1.3
4 h 1.8 3.3 2.8
Figure 6. Dephosphorylation of TDP1 by PP1. Affinity-purified phosphate-
labeled TDP1 from cytoplasmic or nuclear extracts of cells treated with 0 or
20 Gy ionizing radiation was exposed to PP1 and/or YOP phosphatase.
Figure 7. RadiosensitivityofSCAN1cells.Plateau-phasenormalcells(closed
circles, subject 1646) or SCAN1 cells (open squares, subject 1664) were
irradiated daily for 5 days with 0 (A), 0.4 (B), 0.8 (C) or 1.6 (D)G yo f
g-rays, then diluted to 10
5/ml for assessment of cell growth. (E–H) Identical
experiment with another normal and another SCAN1 cell line (subjects 1668
and 1662, respectively).
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been rigorously examined, they both show a strong preference
for recessed 30 termini, and 30 overhangs are extremely poor
substrates for these enzymes even when they bear normal 30-
OH termini (33–35). The Saccharomyces cerevisiae Rad1/
Rad10 endonuclease (and presumably its human ERCC1/
XPF homolog) can remove a single 30-PG (or 30-OH) nucle-
otide from the 30 end of a single-strand break in double-
stranded DNA (36), but no such activity has been reported
on PG-terminated 30 overhangs. Similarly, while Artemis, a
DNA-PK-activated endo/exonuclease, has been implicated in
DSB repair (37), this enzyme appears to act only on 30 over-
hangs longer than four bases (38).
Consistent with these predictions, in extracts of SCAN1
cells harboring mutant TDP1, there was no detectable proces-
sing of a PG terminus on a three-base 30 overhang. Moreover,
despite the fact that puriﬁed TDP1, whether produced in mam-
malian (data not shown) or bacterial (11) cells, is  100-fold
less active toward 30-PG than toward 30-phosphotyrosyl sub-
strates, the levels of TDP1 and PNKP in both whole-cell and
nuclear extracts of normal cells are sufﬁcient to rapidly con-
vert any exposed 30-PG termini to 30-phosphate and then to
30-OH termini (although in nuclear extracts DSB ends appear
to be partially shielded from such processing). Both these
results are consistent with the view that most if not all proces-
sing of protruding 30-PG termini is dependent on TDP1.
Because a substantial proportion, perhaps as many as half, of
DNA breaks induced by ionizing radiation bear 30-PG termini
(7), cells deﬁcient in processing of PG-terminated DSBs are
expected to be profoundly radiosensitive. However, in cell
growth assays, only slight radiosensitivity was detected in
two of three SCAN1 cell lines, and then only for fractionated
radiation in plateau phase. These results suggest that most
PG-terminated DSBs are still repaired in SCAN1 cells, presum-
ably by TDP1-independent pathway(s). As noted above, blunt
and recessed 30-PG ends could be processed by Ape1, while
30 overhangs longer than four bases could be processed
by Artemis. Moreover, for DSBs with one 30-PG and one
30-phosphate terminus, it is possible that the strand with the
30-phosphate could ﬁrst be rejoined, and then the 30-PG strand
could be processed as if it were a single-strand break, with PG
removal by Ape1. Thus, the fraction of radiation-induced DSBs
with a strict requirement for TDP1 (perhaps only those with
one- to four-base PG-terminated 30 overhangs in both strands)
may be quite small, possibly <10%. Finally, even for these
breaks, there may be alternative, more complicated repair path-
ways that can substitute when simpler end-joining pathways
fail, as suggested by the ‘repair foci’ of DSB repair factors
that can be detected cytologically long after the majority of
DSBs have already been repaired (39,40). Failure of these
complexes to form properly in cell extracts could explain the
complete lack of apparent processing in extract-based assays.
Whether protruding PG termini on DSBs are more persistent in
SCAN1 than in normal cells in vivo is not known, and although
a post-labeling assay for PG formation and repair in vivo has
been described previously (41,42), this assay is relatively
insensitive and does not distinguish between single- and dou-
ble-strand break termini. Thus, further work will be required
to resolve the apparent disparity between the profound repair
deﬁciency seen in cell extracts and the relatively mild radio-
sensitivity of SCAN1 cells.
Similar to many DNA repair proteins (28,30,31,43,44),
TDP1 is phosphorylated, and its phosphorylation is stimulated
by ionizing radiation, providing indirect evidence of possible
involvement in pathways for repair of radiation-induced dam-
age. The kinase(s) involved have yet to be identiﬁed, but
phosphorylation on serine/threonine residues as well as stimu-
lation by ionizing radiation would be consistent with ATM
and/or DNA-PK (28,30,31,43–45). Phosphorylation is clearly
not required for the basic enzymatic function of TDP1, as
recombinant proteins produced in bacteria or in human
cells show qualitatively similar activity (H. Tatavarthi and
L. F. Povirk, unpublished data). However, phosphorylation
could modulate TDP1 activity or inﬂuence its interactions
with other repair proteins.
Although not proven, it is generally assumed that SCAN1
pathology is a consequence of the failure of mutant TDP1 to
efﬁciently repair topoisomerase I-associated DNA damage
(12). This repair deﬁciency could indirectly confer sensitivity
to oxidative DNA damage, as certain oxidative lesions tend to
promote formation of topoisomerase I cleavable complexes
(46), which upon replication can be converted to cytotoxic
topoisomerase-terminated DSBs (47). Nevertheless, a role
for PG-terminated DSBs in SCAN1 pathology cannot be
excluded. The neuronal apoptosis seen in knockout mice lack-
ing critical DNA end-joining proteins, such as XRCC4 and
DNA ligase IV (48,49), suggest that in the absence of DSB
repair, terminally differentiating neurons accumulate sufﬁ-
cient DSBs to produce signiﬁcant neurological pathology.
There is evidence that at least some of these ‘spontaneous’
DSBs reﬂect damage by oxygen free radicals associated with
normal oxidative metabolism (50). Moreover, SCAN1 patho-
logy is similar to that of both Friedreich ataxia and ataxia with
oculomotor apraxia (AOA1) (51), both of which have been
linkedtooxidativedamage.Friedreichataxiaisassociatedwith
a mutant frataxin protein, which leads to increased oxidative
stress due to a defect in iron homeostasis (52–56). AOA1
cells are sensitive to hydrogen peroxide and harbor a mutation
in aprataxin; while the exact function of the aprataxin protein
is not known, it interacts with the single-strand break
repair protein XRCC1. In S.cerevisiae of appropriate genetic
backgrounds, TDP1 deﬁciency confers sensitivity to ionizing
radiation as well as to bleomycin, a radiomimetic drug that
speciﬁcallyinducesPG-terminated DSBs (57).Thus, whilethe
exact sequence of events culminating in the SCAN1 pheno-
type remains to be elucidated, several lines of circumstantial
evidence suggest a possible linkage among TDP1 deﬁciency,
oxidative damage, DSBs and cerebellar ataxia. Even though
lymphoblastoid cell lines derived from SCAN1 patients
show at most only mild radiosensitivity, it is possible that
endogenous tissues of SCAN1 patients are more sensitive
to free radical damage than the cell lines. Because cultured
cells are subjected to higher oxygen tensions than would occur
in vivo, they may be more likely to adapt to TDP1 deﬁciency,
for example, by upregulating alternative pathwaysfor repair of
DSBs and other oxidative damage.
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